Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients-Results from the CORONA Germany Study.

ABSTRACT:

Background

Acute myocardial injury (AMJ), assessed by elevated levels of cardiac troponin, is associated with fatal outcome in coronavirus disease 2019 (COVID-19). However, the role of acute cardiovascular (CV) events defined by clinical manifestation rather than sole elevations of biomarkers is unclear in hospitalized COVID-19 patients.

Objective

The aim of this study was to investigate acute clinically manifest CV events in hospitalized COVID-19 patients.

Methods

From 1 March 2020 to 5 January 2021, we conducted a multicenter, prospective, epidemiological cohort study at six hospitals from Hamburg, Germany (a portion of the state-wide 45-center CORONA Germany cohort study) enrolling all hospitalized COVID-19 patients. Primary endpoint was occurrence of a clinically

SUBMITTER: Gunawardene MA 

PROVIDER: S-EPMC8432202 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature